Intragastric Balloon Market Size

Market Outlook:

Intragastric Balloon Market crossed USD 45.45 Million in 2023 and is estimated to reach USD 101.18 Million by end of the year 2032, growing at over 9.3% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 45.45 Million
• CAGR (2024-2032): 9.3%
• Forecast Year Value (2032): USD 101.18 Million
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

The increasing prevalence of obesity worldwide is driving the growth of the intragastric balloon market. Obesity is a major risk factor for various chronic diseases, including diabetes, cardiovascular diseases, and certain types of cancer, creating a strong demand for non-surgical weight loss solutions such as intragastric balloons. The rising awareness about the health risks associated with obesity and the importance of weight management is also contributing to the market growth.

Another major growth driver for the intragastric balloon market is the technological advancements in intragastric balloon devices. Manufacturers are constantly innovating to improve the safety and efficacy of intragastric balloons, leading to the development of advanced balloon designs with better durability and patient comfort. These technological advancements are attracting more patients towards intragastric balloon procedures and expanding the market size.

The growing preference for minimally invasive weight loss procedures is also fueling the growth of the intragastric balloon market. Intragastric balloon placement is a less invasive alternative to bariatric surgery, offering a shorter recovery time, lower risk of complications, and reversible weight loss outcomes. As patients increasingly seek less invasive weight loss options, the demand for intragastric balloons is expected to continue rising.

Industry

Report Scope

Report Coverage	Details
Segments Covered	Balloon Type, Filling Material, Administration, End-use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Allurion Technologies, Allergan, Apollo Endosurgery, Reshape Medical, Spatz FGIA, Endalis, Silimed, Medsil

However, despite the growth drivers, there are also some restraints impacting the intragastric balloon market. A significant restraint is the high cost of intragastric balloon procedures. The cost of intragastric balloon placement can be a barrier for many patients, especially in regions with limited insurance coverage for weight loss interventions. The high out-of-pocket expenses associated with intragastric balloons can limit the market penetration and adoption rates.

Moreover, a significant restraint for the intragastric balloon market is the potential side effects and complications associated with the procedure. While intragastric balloons are generally considered safe, there are risks of adverse events such as gastric ulceration, migration, and bowel obstruction. The occurrence of these complications, although rare, can deter some patients from opting for intragastric balloon procedures, leading to a slower market growth.